Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

BRIMONIDINE TARTRATE; TIMOLOL MALEATE

BRIMONIDINE TARTRATE; TIMOLOL MALEATE

Standard Dose
0.2%; 0.5%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: None (Tentative Approval)
Summary

Approval overview BRIMONIDINE TARTRATE; TIMOLOL MALEATE is listed in Drugs@FDA under application 091574 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient BRIMONIDINE TARTRATE; TIMOLOL MALEATE Form and strength SOLUTION; OPHTHALMIC - 0.2%; 0.5% Sponsor ALCON Submission history Latest submission status date: 2010-08-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview BRIMONIDINE TARTRATE; TIMOLOL MALEATE is listed in Drugs@FDA under application 091574 (ANDA). Marketing status: None (Tentative Approval) Active ingredient BRIMONIDINE TARTRATE; TIMOLOL MALEATE Form and strength SOLUTION; OPHTHALMIC - 0.2%; 0.5% Sponsor ALCON Submission history Latest submission status date: 2010-08-03 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)

Interaction Notes

  • No interaction notes stored yet.